Prudent Man Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$322K Buy
1,101
+382
+53% +$126K 0.1% 123
2025
Q4
$252K Hold
719
0.09% 126
2025
Q3
$232K Sell
719
-539
-43% -$168K 0.09% 128
2025
Q2
$489K Buy
1,258
+1
+0.1% +$402 0.16% 121
2025
Q1
$547K Buy
1,257
+28
+2% +$11.2K 0.2% 115
2024
Q4
$453K Sell
1,229
-253
-17% -$106K 0.16% 120
2024
Q3
$771K Sell
1,482
-26
-2% -$13.9K 0.26% 93
2024
Q2
$817K Buy
1,508
+68
+5% +$35.9K 0.29% 82
2024
Q1
$747K Sell
1,440
-2
-0.1% -$995 0.28% 87
2023
Q4
$680K Sell
1,442
-93
-6% -$43K 0.25% 89
2023
Q3
$668K Buy
1,535
+5
+0.3% +$2.27K 0.27% 88
2023
Q2
$680K Sell
1,530
-22
-1% -$10.1K 0.26% 84
2023
Q1
$714K Sell
1,552
-38
-2% -$18.1K 0.28% 80
2022
Q4
$816K Buy
1,590
+6
+0.4% +$3.05K 0.33% 69
2022
Q3
$720K Sell
1,584
-242
-13% -$116K 0.34% 60
2022
Q2
$881K Buy
1,826
+440
+32% +$218K 0.41% 47
2022
Q1
$681K Sell
1,386
-20
-1% -$9.14K 0.28% 76
2021
Q4
$652K Sell
1,406
-432
-24% -$182K 0.25% 81
2021
Q3
$685K Sell
1,838
-39
-2% -$14.8K 0.26% 79
2021
Q2
$717K Sell
1,877
-30
-2% -$11.5K 0.28% 75
2021
Q1
$685K Buy
1,907
+49
+3% +$15.8K 0.29% 74
2020
Q4
$597K Sell
1,858
-26
-1% -$7.98K 0.25% 78
2020
Q3
$506K Buy
1,884
+14
+0.7% +$3.77K 0.27% 78
2020
Q2
$492K Buy
+1,870
New +$499K 0.44% 64

Other funds holding ELV

Prudent Man Advisors's ELV Position: Q1 2026 in Review

Prudent Man Advisors increased its Elevance Health (ELV) stake by 53% in Q1 2026, buying an estimated $126K and bringing the position to 1,101 shares worth $322K. The position accounts for 0.1% of the portfolio, ranked #123.

Prudent Man Advisors first reported a position in ELV in Q2 2020 and has held it in 24 quarters since. The position peaked at $881K in Q2 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Prudent Man Advisors held 1,101 shares of Elevance Health worth $322K as of Q1 2026.
  • Prudent Man Advisors bought 382 Elevance Health shares in Q1 2026, an estimated $126K.
  • Elevance Health made up 0.1% of Prudent Man Advisors's portfolio in Q1 2026, its #123 holding.
  • Prudent Man Advisors first reported a position in Elevance Health in Q2 2020 and has held it in 24 quarters since.
  • Prudent Man Advisors's Elevance Health position peaked at $881K in Q2 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Prudent Man Advisors's 13F filing for Q1 2026, filed 8 May 2026.